Does the Platelet-Activated Clotting Test (HemoSTATUSR) Predict Blood Loss and Platelet Dysfunction Associated with Cardiopulmonary Bypass?.
According to the authors’ abstract of an article published in Anesthesia and Analgesia, “Platelet dysfunction is a major cause of bleeding after cardiopulmonary bypass (CPB). No timely, simple, point-of-care determinant of platelet function is available for clinical use. Adding platelet-activating factor to conventional activated clotting time methods (platelet-activated clotting test [PACT]) (HemoSTATUSR; Medtronic, Inc., Parker, CO) produces rapid results (<3 min) and may yield a measure of platelet responsiveness and whole blood procoagulant activity. Blood samples were drawn for PACT, platelet count, prothrombin time, activated partial thromboplastin time, and...
Related Questions
- Does the Platelet-Activated Clotting Test (HemoSTATUSR) Predict Blood Loss and Platelet Dysfunction Associated with Cardiopulmonary Bypass?.
- Does the platelet-activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass?
- Are ultrasonographic myoma characteristics associated with blood loss at delivery?
